Tag: biomedical
-

Trial Testing DNA Antibody Vaccine for Zika
A clinical trial is enrolling participants testing a vaccine to prevent Zika infections with synthetic DNA particles designed to produce antibodies against the virus.
-

Algorithms Identify More Genetic Syndromes
An analysis of facial images with computer vision and deep learning returned more accurate identifications of genetic syndromes than 3 panels of trained clinicians
-

Genetic Acids Harnessed to Promote Wound Healing
A bioengineering team designed a way to use acids in DNA that in lab tests promote wound repair by encouraging production of healing proteins in surrounding tissues.
-

Tissue Chip, A.I. Companies Partner on Heart Drug Discovery
A developer of chip devices emulating heart tissue and a medical analytics company using artificial intelligence are jointly discovering new drugs to treat aging heart muscles.
-

Lilly Buys Precision Cancer Company in $8B Deal
Drug maker Eli Lilly and Company is acquiring a developer of cancer therapies that target specific genetic alterations rather than tumors in the body.
-

Inhaled Messenger RNA Developed, Tested
An academic-industry team developed an inhaled form of genetic material in nanoscale particles that enables lab mice to safely produce proteins in their lungs.
-

AI, Wearables Posing Health Privacy Risks
An analysis shows artificial intelligence algorithms can connect Americans’ activity tracking data to to their individual private medical information.
-

Trial Testing Breath Detection for Cancer
A clinical trial is recruiting participants to test a technology that analyzes exhaled breath for indicators of specific types of cancer.
-

Brain Stimulation, Recording Device Advances
An implanted device that both records activity and stimulates precise brain regions is shown to operate in lab monkeys, advancing its potential for neurological diseases.
-

Duchenne Stem Cell Trial Halted
A clinical trial testing stem cell treatments for symptoms of Duchenne muscular dystrophy is on hold after a patient reported a severe reaction.